167 related articles for article (PubMed ID: 6382283)
1. The role of systemic chemotherapy in advanced bladder cancer.
van Groeningen CJ; Stoter G
Prog Clin Biol Res; 1984; 153():381-93. PubMed ID: 6382283
[No Abstract] [Full Text] [Related]
2. Systemic therapy of bladder cancer.
Salem PA
Prog Clin Biol Res; 1984; 162B():95-105. PubMed ID: 6209726
[No Abstract] [Full Text] [Related]
3. Chemotherapy as an adjuvant to cystectomy and for advanced urothelial cancer.
Loening S
Urol Clin North Am; 1984 Nov; 11(4):699-708. PubMed ID: 6390915
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.
Lehmann J; Retz M; Stöckle M
World J Urol; 2002 Aug; 20(3):144-50. PubMed ID: 12196897
[TBL] [Abstract][Full Text] [Related]
5. [Value of preoperative chemotherapy in the treatment of invasive cancer of the bladder].
Denis L; Hendrickx G; Braeckman J; Debruyne R
Acta Urol Belg; 1984; 52(4):579-82. PubMed ID: 6542746
[No Abstract] [Full Text] [Related]
6. [Is neoadjuvant chemotherapy valid in invasive cancer of the bladder?].
Matveev BP; Figurin KM
Urol Nefrol (Mosk); 1998; (6):42-5. PubMed ID: 10051828
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.
Nieuwenhuijzen JA; Bex A; Meinhardt W; Kerst JM; Schornagel JH; VAN Tinteren H; Horenblas S
J Urol; 2005 Jul; 174(1):80-5. PubMed ID: 15947583
[TBL] [Abstract][Full Text] [Related]
8. The evolution of active chemotherapy in metastatic and locally advanced bladder cancer.
Newling DW
Prog Clin Biol Res; 1990; 350():115-27. PubMed ID: 2201038
[No Abstract] [Full Text] [Related]
9. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
Walther PJ
Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
[No Abstract] [Full Text] [Related]
10. Systemic chemotherapy in the management of advanced bladder cancer.
Hall RR
Arch Esp Urol; 1990; 43 Suppl 2():193-6. PubMed ID: 2096778
[No Abstract] [Full Text] [Related]
11. Chemotherapy for metastatic bladder cancer.
Kantoff PW; Scher HI
Hematol Oncol Clin North Am; 1992 Feb; 6(1):195-203. PubMed ID: 1556050
[TBL] [Abstract][Full Text] [Related]
12. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for advanced urothelial cancer.
Yagoda A
Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
[No Abstract] [Full Text] [Related]
14. [Chemotherapy of bladder tumors].
Vallet D; Cappelaere P; Adenis L; Demaille A
Lille Med; 1978; 23(7):486-9. PubMed ID: 364222
[No Abstract] [Full Text] [Related]
15. Tyrosine kinase inhibitors of the epidermal growth factor receptor as adjuncts to systemic chemotherapy for muscle-invasive bladder cancer.
McHugh LA; Griffiths TR; Kriajevska M; Symonds RP; Mellon JK
Urology; 2004 Apr; 63(4):619-24. PubMed ID: 15072863
[No Abstract] [Full Text] [Related]
16. Perioperative chemotherapy for the management of primary local regional urothelial tumors.
Logothetis CJ
Prog Clin Biol Res; 1985; 201():359-66. PubMed ID: 3841594
[No Abstract] [Full Text] [Related]
17. Systemic chemotherapy of carcinoma of the urinary bladder.
Maral J; Chamseddine N; Auclerc G; Jacquillat C
Prog Clin Biol Res; 1984; 162B():107-12. PubMed ID: 6542216
[No Abstract] [Full Text] [Related]
18. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
[TBL] [Abstract][Full Text] [Related]
19. Bladder cancer: management of advanced disease.
Chong CD
Tex Med; 1987 Feb; 83(2):51-4. PubMed ID: 3824246
[No Abstract] [Full Text] [Related]
20. [Clinical evaluation of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced urothelial cancer].
Mikami K; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Nakao M
Hinyokika Kiyo; 1994 Apr; 40(4):303-7. PubMed ID: 8191968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
